Airsculpt Technologies, Inc. (AIRS): Price and Financial Metrics
GET POWR RATINGS... FREE!
AIRS Stock Price Chart Interactive Chart >
AIRS Price/Volume Stats
Current price | $10.56 | 52-week high | $18.48 |
Prev. close | $8.88 | 52-week low | $5.79 |
Day low | $10.53 | Volume | 278,643 |
Day high | $11.49 | Avg. volume | 171,730 |
50-day MA | $7.41 | Dividend yield | N/A |
200-day MA | $0.00 | Market Cap | 587.56M |
Airsculpt Technologies, Inc. (AIRS) Company Bio
AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of October 5, 2021, it operated 16 centers across 13 states. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Latest AIRS News From Around the Web
Below are the latest news stories about Airsculpt Technologies Inc that investors may wish to consider to help them evaluate AIRS as an investment opportunity.
AirSculpt Technologies Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Conference CallMIAMI BEACH, Fla., Feb. 18, 2022 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) today announced that the company will release its fourth quarter and full year results before market open on Friday, March 11, 2022, to be followed by a conference call on the same day at 8:30 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-9716 or for international callers, 1-201-493-6779. A replay will be available two hours after the |
Act Capital Management, Llc Buys Adtran Inc, Meta Platforms Inc, Vir Biotechnology Inc, Sells , ...Investment company Act Capital Management, Llc (Current Portfolio) buys Adtran Inc, Meta Platforms Inc, Vir Biotechnology Inc, AirSculpt Technologies Inc, enVVeno Medical Corp, sells , Upstart Holdings Inc, Affirm Holdings Inc, Nektar Therapeutics, Nuance Communications Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Act Capital Management, Llc. |
Is AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) ROE Of 28% Impressive?While some investors are already well versed in financial metrics (hat tip), this article is for those who would like... |
Arthur M. Cohen & Associates, Llc Buys Invesco NASDAQ 100 ETF, General Electric Co, ...Investment company Arthur M. Cohen & Associates, Llc (Current Portfolio) buys Invesco NASDAQ 100 ETF, General Electric Co, RingCentral Inc, Ford Motor Co, S&P MidCap 400 ETF, sells Ansys Inc, BTC iShares MSCI USA Momentum Factor ETF, Wynn Resorts, Church & Dwight Co Inc, The Trade Desk Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Arthur M. |
Analysts Are Bullish on Top Healthcare Stocks: Arvinas Holding Company (ARVN), Edgewise Therapeutics (EWTX)There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research Report), Edgewise Therapeutics (EWTX – Research Report) and Airsculpt Technologies, Inc. (AIRS – Research Report) with bullish sentiments. Arvinas Holding Company (ARVN) In a report released yesterday, Christopher Liu from Leerink Partners maintained a Buy rating on Arvinas Holding Company, with a price target of $115.00. The company's shares closed last Monday at $75.65. According to TipRanks. |
AIRS Price Returns
1-mo | 65.78% |
3-mo | 19.73% |
6-mo | -24.63% |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | -38.57% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
2018 | N/A |
2017 | N/A |
Loading social stream, please wait...